A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer

查看全文 作　　者：Xin-shuai [1]WANG;De-jiu [1]KONG;Tzu-yin [2]LIN;Xiao-cen [4]LI;Yoshihiro [3]IZUMIYA;Xue-zhen [1]DING;Li [1]ZHANG;Xiao-chen [1]HU;Jun-qiang [1]YANG;She-gan [1]GAO;Kit [4]SLAM;Yuan-pei [4]LI

机构地区：[1]Henan Key Laboratory of Cancer Epigenetics; Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang 471003, China;[2]Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis, Sacramento, CA 95817, USA;[3]Department of Dermatology, University of California Davis, Sacramento, CA 95817, USA;[4]Department of Biochemistry & Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA 95817, USA

出　　处：《Acta Pharmacologica Sinica》索引2017年第38卷第6期,共12页

关键词：食管癌细胞联合治疗协同组平台体外抗肿瘤活性多功能 DCMS 抗癌药物

相关文献

参考文献（48）
引证文献（6）
耦合文献（0）

参考文献(48)

引证文献(6)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer

参考文献(48)

引证文献(6)

用户提示